• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

MOV10 sequesters the RNP of influenza A virus in the cytoplasm and is antagonized by viral NS1 protein

tetano

Editor, Senior Moderator
Biochem J. 2019 Jan 7. pii: BCJ20180754. doi: 10.1042/BCJ20180754. [Epub ahead of print]
[h=1]MOV10 sequesters the RNP of influenza A virus in the cytoplasm and is antagonized by viral NS1 protein.[/h] Li J[SUP]1[/SUP], Hu S[SUP]2[/SUP], Xu F[SUP]2[/SUP], Mei S[SUP]2[/SUP], Liu X[SUP]2[/SUP], Yin L[SUP]2[/SUP], Zhao F[SUP]1[/SUP], Zhao X[SUP]1[/SUP], Sun H[SUP]2[/SUP], Xiong Z[SUP]1[/SUP], Zhang D[SUP]1[/SUP], Cen S[SUP]3[/SUP], Wang J[SUP]4[/SUP], Liang C[SUP]5[/SUP], Guo F[SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] MOV10 has emerged as an important host antiviral factor. MOV10 not only inhibits various viruses including human immunodeficiency virus type 1, hepatitis C virus and vesicular stomatitis virus, it also restricts the activity of retroelements LINE-1, Alu, SVA and IAP. Here we report that MOV10 suppresses influenza A virus infection through interacting with viral nucleoprotein, sequestering viral RNP in the cytoplasm and causing the degradation of viral vRNA. This antiviral activity of MOV10 depends on the integrity of P-bodies. We also found that the antiviral activity of MOV10 is partially countered by viral NS1 protein that interferes with the interaction of MOV10 with viral nucleoprotein and causes MOV10 degradation through the lysosomal pathway. Moreover, NS1 defective IAV is more susceptible to MOV10 restriction. Our data not only expand the antiviral spectrum of MOV10, but more importantly reveal the NS1 protein as the first viral antagonist of MOV10.
?2019 The Author(s).


[h=4]KEYWORDS:[/h] Influenza A virus; MOV10; NS1; P-bodies

PMID: 30617221 DOI: 10.1042/BCJ20180754
 
Back
Top